Latest News | Zydus Life Gets Final USFDA Approval to Manufacture, Market Ulcer Drug
Get latest articles and stories on Latest News at LatestLY. Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market sucralfate tablets used in the treatment and prevention of ulcers in the intestines.
New Delhi, May 4 (PTI) Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market sucralfate tablets used in the treatment and prevention of ulcers in the intestines.
The approval granted by the US Food and Drug Administration (USFDA) is to manufacture and market Sucralfate Tablets of strength 1 gram, Zydus Lifesciences said in a regulatory filing.
Also Read | Climate Change: 82 Percent of Indians Either Alarmed or Concerned About Global Warming, Says Study.
The drug will be manufactured at the group's topical manufacturing facility at SEZ, Ahmedabad, it added.
Sucralfate is used to treat and prevent ulcers in the intestines by forming a coating over ulcers, protecting the area from further injury, and thus helps ulcers heal more quickly, the company said.
Sucralfate tablets 1 gram had annual sales of USD 84 million in the US, it said citing IQVIA MAT February 2023 data.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)